share_log

TCR2 Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(7.3%),TANG CAPITAL MANAGEMENT, LLC(7.3%), etc.

TCR2 Therapeutics | SC 13G:超過5%持股股東披露文件-TANG CAPITAL PARTNERS, LP(7.3%),TANG CAPITAL MANAGEMENT, LLC(7.3%)等

2022/03/04 16:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息